167 related articles for article (PubMed ID: 29751732)
1. Population Screening for Hemoglobinopathies.
Goonasekera HW; Paththinige CS; Dissanayake VHW
Annu Rev Genomics Hum Genet; 2018 Aug; 19():355-380. PubMed ID: 29751732
[TBL] [Abstract][Full Text] [Related]
2. Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.
Amato A; Grisanti P; Lerone M; Ponzini D; Di Biagio P; Cappabianca MP; Giordano PC
Prenat Diagn; 2009 Dec; 29(12):1171-4. PubMed ID: 19816879
[TBL] [Abstract][Full Text] [Related]
3. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for hemoglobinopathies in California.
Michlitsch J; Azimi M; Hoppe C; Walters MC; Lubin B; Lorey F; Vichinsky E
Pediatr Blood Cancer; 2009 Apr; 52(4):486-90. PubMed ID: 19061217
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
[TBL] [Abstract][Full Text] [Related]
6. New Born Screening of Hemoglobinopathies in a Center Tunisian Population.
Chaouch L; Moumni I; Ben Abdallah J; Bouchahda R; Methlouthi J; Mahdhaoui N; Matamri W; Braham N; Bouguila F; Mejri L; Charefeddine B; Chaieb A; Khairi H; Menif S
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e296-e299. PubMed ID: 38748601
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Hemoglobinopathy in Nepalese Population.
Shrestha RM; Pandit R; Yadav UK; Das R; Yadav BK; Upreti HC
J Nepal Health Res Counc; 2020 Apr; 18(1):52-58. PubMed ID: 32335593
[TBL] [Abstract][Full Text] [Related]
8. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
9. Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: high performance liquid chromatography studies in 9000 patients.
Baruah MK; Saikia M; Baruah A
Indian J Pathol Microbiol; 2014; 57(2):236-43. PubMed ID: 24943756
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for hemoglobin disorders.
Hoppe CC
Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
[TBL] [Abstract][Full Text] [Related]
11. Preventation of thalassemia in Australia.
Hendy J
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():94-6. PubMed ID: 11400797
[TBL] [Abstract][Full Text] [Related]
12. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal screening of hemoglobinopathies in a population residing in Portugal].
Peres MJ; Carreiro MH; Machado MC; Seixas T; Picanço I; Batalha L; Lavinha J; Martins MC
Acta Med Port; 1996; 9(4-6):135-9. PubMed ID: 9005686
[TBL] [Abstract][Full Text] [Related]
14. National registry of hemoglobinopathies in Spain (REPHem).
Cela E; Bellón JM; de la Cruz M; Beléndez C; Berrueco R; Ruiz A; Elorza I; Díaz de Heredia C; Cervera A; Vallés G; Salinas JA; Coll MT; Bermúdez M; Prudencio M; Argilés B; Vecilla C;
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27804209
[TBL] [Abstract][Full Text] [Related]
15. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
Schoen EJ; Marks SM; Clemons MM; Bachman RP
Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
[TBL] [Abstract][Full Text] [Related]
16. Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India: Experience of 18,166 cases.
Chatterjee T; Chakravarty A; Chakravarty S
Hemoglobin; 2015; 39(6):384-8. PubMed ID: 26428539
[TBL] [Abstract][Full Text] [Related]
17. Preimplantation genetic diagnosis for hemoglobinopathies.
Kuliev A; Pakhalchuk T; Verlinsky O; Rechitsky S
Hemoglobin; 2011; 35(5-6):547-55. PubMed ID: 21910603
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Rodriguez-Capote K; Higgins TN
Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
[TBL] [Abstract][Full Text] [Related]
19. Prenatal and newborn screening for hemoglobinopathies.
Hoppe CC
Int J Lab Hematol; 2013 Jun; 35(3):297-305. PubMed ID: 23590658
[TBL] [Abstract][Full Text] [Related]
20. The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
Wang HC; Hsieh LL; Liu YC; Hsiao HH; Lin SK; Tsai WC; Liu TC
Ann Hematol; 2017 Feb; 96(2):183-188. PubMed ID: 27891555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
